DNDi and founders’ symposium

Best science for the most neglected: How can needs-driven R&D advance universal health coverage?

29-30 October 2019
Berlin, Germany

  • On the sidelines of the World Health Summit in Berlin, DNDi is convening a high-level policy discussion on the possibilities and opportunities created by alternative models and innovative approaches to public-interest R&D to deliver urgently needed innovations of public health importance, and to achieve Universal Health Coverage and the Sustainable Development Goals.


16-20 September 2019
Liverpool, UK

  • DND– one symposium on cutaneous leishmaniasis and one on mycetoma
  • Nathalie Strub-Wourgaft, NTD Director – session on advocacy networks addressing NTDs


28-30 August 2019
Yokohama, Japan

  • Monique Wasunna, Director DNDi Africa – symposium on NTDs in Africa and partnerships with Japan

MedTrop 2019

Congress of the Brazilian Society of Tropical Medicine

28-31 July 2019
Belo Horizonte, Brazil

  • DNDi participating in several round tables and doing presentations on Chagas disease, leishmaniasis, and hepatitis C

PAGE 2019 Meeting

11-14 June 2019
Stockholm, Sweden

  • Posters on visceral leishmaniasis and paediatric HIV

Chagas disease – Breaking the Silence

22 May 2019
Geneva, Switzerland

  • DNDi co-organizing – panel discussion to discuss the major hurdles preventing access to quality care and treatment and how the global health community can best move forwards to eradicate Chagas disease

Wellcome Centre for Anti-Infective Research at the University of Dundee

12-15 May 2019
Dundee, UK

  • Isabela Ribeiro, Head of Dynamic Portfolio Unit – presentation on clinical trials for Chagas disease
  • Nick White, Chair DNDi SAC – presentation on the global situation in infectious diseases & drug discovery for infectious diseases
  • Poster presentations on drug discovery projects for Chagas disease and leishmaniasis

SADI 2019

9-11 May 2019
Tucuman, Argentina

  • Sergio Sosa-Estani, Head of Chagas Clinical Programmes – presentation of the BENDITA trial results and the benznidazole monotherapy strategy

MSF Scientific Days

9-10 May 2019
London, UK

  • Fabiana Barreira, Chagas Senior Clinical Manager – presentation of the BENDITA trial for Chagas disease
  • Nathalie Strub-Wourgaft, Director NTDs – presentation on registration steps for the new all oral sleeping sickness treatment